Arca Biopharma reported $4.1M in Operating Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Amgen AMGN:US $ 4.33B 1.37B
Arca Biopharma ABIO:US $ 4.1M 2.11M
Biogen BIIB:US $ 1984.9M 304.4M
Brainstorm Cell Therapeutics BCLI:US $ 5.28M 844K
Bristol Myers Squibb BMY:US $ 9.63B 360M
Capricor Therapeutics CAPR:US $ 4.31M 654.54K
Cytokinetics CYTK:US $ 74.64M 17M
Cytrx CYTR:US 1.53M 351.4K
Daiichi Sankyo 4568:JP 226.92B 8.62B
Gilead Sciences GILD:US $ 3579M 392M
GlaxoSmithKline GSK:LN 7.14B 722M
Laboratory Of America LH:US $ 3295.7M 154.1M
Myriad Genetics MYGN:US $ 247.2M 37M
Otsuka Holdings 4578:JP Y 341641M 20691M
Pfizer PFE:US $ 16447M 3384M
United Therapeutics UTHR:US $ 216M 10.6M